DGAP-Adhoc: STADA in exclusive negotiations on the purchase

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
DGAP-Adhoc: STADA in exclusive negotiations on the purchase of the British OTC manufacturer Thornton & Ross

STADA Arzneimittel AG / Key word(s): Miscellaneous 06.08.2013 10:38 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Bad Vilbel, August 6, 2013 - STADA Arzneimittel AG and the owners of Thornton & Ross Ltd. have today agreed to negotiate exclusively on the purchase of the British OTC manufacturer. Based in Huddersfield, Thornton & Ross was founded in 1922 and has a number of well-known prescription-free (OTC) branded products for a wide variety of indications - among other things, cold, pain and dermatology. In financial year 2012/2013 (April 1, 2012 - March 31, 2013), Thornton & Ross generated sales of GBP 66.233 million (at the current exchange rate approximately Euro 76.66 million) and thereby approximately 11 percent more than in the previous year - for the most part through the pharmacy and drugstore distribution channels in the United Kingdom. The EBITDA margin in 2012/2013 was above the average for the STADA Group. Thornton & Ross is currently one of the fastest-growing companies in the British pharmaceutical market and at the same time number 5 in the British OTC market. Thornton & Ross has an EU-GMP-certified production site and currently employs approximately 425 people. The contract signing and completion of the acquisition are planned for the third quarter of the current financial year. Consolidation of sales is sought from September 2013. Payment of the purchase price will be made at the time of completion. STADA will use cash on hand and existing free credit lines to finance the acquisition. It is expected that the transaction will contribute to net income from the time of consolidation. With a successful acquisition, the STADA Group will strengthen its business activities in the British pharmaceutical market in the segment for branded products for self-medication, which is especially strategically important. In addition, the acquisition provides STADA with the opportunity to also introduce prescription-free branded products from the comprehensive Group portfolio in the British market in the future. Additional information: STADA Arzneimittel AG / Corporate Communications / Stadastra�e 2-18 / 61118 Bad Vilbel - Germany / Phone: +49 (0) 6101 603-113 / Fax: +49 (0) 6101 603-506 / E-mail: communications@stada.de Or visit us in the Internet at www.stada.com. 06.08.2013 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: STADA Arzneimittel AG Stadastra�e 2-18 61118 Bad Vilbel Germany Phone: +49 (0)6101 603- 113 Fax: +49 (0)6101 603- 506 E-mail: communications@stada.de Internet: www.stada.de ISIN: DE0007251803, DE0007251845, WKN: 725180, 725184, Indices: MDAX Listed: Regulierter Markt in Düsseldorf, Frankfurt (Prime Standard); Freiverkehr in Berlin, Hamburg, Hannover, München, Stuttgart End of Announcement DGAP News-Service ---------------------------------------------------------------------------

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Aetna's 2027 Medicare Plans: Comprehensive Outlook

Updated Category News Views 3

Unpacking Aetna's Medicare Strategy for 2027 Look, if there's one thing you should keep tabs on, it's how Aetna isn't just coasting by in the healthcare arena. These folks are pushing forward with new options for 2027 that prove they're serious about making healthcare not just accessible, but affordable across the board. Aetna, backed by CVS Health (NYSE: CVS), is making...

Continue Reading
Honeywell's Supply Line Snags Bait Class Action Risk

Updated Category News Views 11

Stepping into the chaos of the stock market sometimes feels like opening Pandora's box—just when you think you've seen it all, something new tumbles out. This time around, it's Honeywell Aerospace (NasdaqGS: HONA) playing catch with hot coals, and a burning class-action lawsuit smolders in the air. Deadline Looms for Investors in Class Action Heads up, folks! If you've...

Continue Reading
The Real Cost of Cabinet Decisions: Refinish or Replace?

Updated Category News Views 3

Uncovering the Truth Behind Cabinet Decisions When it comes to sprucing up a kitchen, most folks overlook what's hanging on their walls already: those tired old cabinets. Now, are you looking at chucking them out the window for brand-new ones, or can a fresh coat of paint breathe new life into them? Well, that's where Melvin Jones, a painting virtuoso from Lexington,...

Continue Reading
Kal Plastics Showcases at Design-2-Part Expo

Updated Category News Views 3

Kal Plastics Steps into the Limelight There's a buzz in the air, and it's all about Kal Plastics getting ready to strut their stuff at the Southern California Design-2-Part Show. Now, most folks probably don't spend their nights dreaming about thermoforming and pressure forming, but these guys sure make a case for it. They’ve got their eyes on impressing the crowd with...

Continue Reading
Govee Stirs Halloween Chills with New Sarah Gellar Ad

Updated Category News Views 4

Lighting Up Halloween the Hollywood Way When it comes to Halloween, folks go nuts driving up the thrill factor at home, and boy, has Govee nailed it this time around. They've dragged Sarah Michelle Gellar into their spooky mix, transforming homes into eerie masterpieces. And let's face it, who better than the 'Buffy the Vampire Slayer' herself to stir those spine-tingling...

Continue Reading
Ractigen's Breakthrough in DMD: RNA Activates Utrophin

Updated Category News Views 3

Ractigen's New Fight Against Duchenne: A Personal Take When it comes to biotech advancements, I've seen enough breakthroughs to not get swayed easily. But Ractigen Therapeutics presenting their first-in-human data on RNA activation for Duchenne Muscular Dystrophy (DMD) kind of demands your attention. Folks, they're talking about a potential shift in handling this brutal...

Continue Reading
Venice's Climate Challenge: Rising Seas, Sinking Lands

Updated Category News Views 3

Sea Rise Isn’t Just a Statistics Problem The ordeal of rising seas isn't just about staring at numbers in some spreadsheet, it's a real-world gut punch that's knocking at Venice's door. This city, known for its stunning architecture and winding canals, now serves as the poster child for what happens when Mother Nature and human errors leave a place on the brink of...

Continue Reading
Trading Platforms Poised for Billions by 2031

Updated Category News Views 5

Forecasts and Fierce Digital Landscapes Just when you thought the online trading realm was getting saturated, the numbers are making it clear: there’s still room for growth—even explosive growth. The online trading platform market is eyeing a hike, jumping from a $11.65 billion valuation in 2025 to a projected $18.18 billion by 2031, according to Mordor Intelligence....

Continue Reading
Vatrer Power: Lithium Batteries Revolutionize Golf Carts

Updated Category News Views 3

The humdrum world of golf carts just got a jolt of energy with lithium batteries entering the fray. Vatrer Power, the brain behind some nifty LiFePO4 lithium battery conversions, made some noise at this year's Golf Carting Expo & Dealer Summit in Charleston, South Carolina. Held at the North Charleston Convention Center, this trade show was the industry's premier...

Continue Reading

Top 5 Most Recently Viewed Articles

Encore Capital Group Prepares for First Quarter Release

Updated Category News Views 354

Encore Capital Group to Report Q1 2025 Financial Results Encore Capital Group, Inc. (Nasdaq:ECPG) is setting the stage for its financial results announcement for the first quarter of the year. This highly anticipated event will take place on a Wednesday in early May. Stakeholders and the public alike are invited to tune in as important financial metrics will be shared,...

Continue Reading
Corteva's Q3 Success and Updated 2025 Financial Outlook

Updated Category News Views 242

Overview of Corteva's Financial Performance Corteva, Inc. (NYSE: CTVA) has recently made headlines with strong financial performance, having reported positive results for the third quarter and for the year-to-date 2025. As a leading entity in the agricultural sector, Corteva attributes its performance to robust volume growth in both its Crop Protection and Seed segments....

Continue Reading
Insights from Ring Energy's Latest Sustainability Report

Updated Category News Views 337

Overview of Ring Energy's 2024 Sustainability Report Ring Energy, Inc. has officially released its latest sustainability report for 2024, reflecting its ongoing commitment to transparency and responsible practices. This report marks the fourth successive annual update, showcasing the company's dedication to advancing Environmental, Social, and Governance (ESG)...

Continue Reading
Tesla's Rising Sales Amid Intense Competition from Rivals

Updated Category News Views 188

Tesla's Sales Surge Amidst Growing Competition Tesla Inc (NASDAQ: TSLA) has recently seen a remarkable increase in its electric vehicle (EV) sales in China, demonstrating its ability to thrive in a highly competitive market. In August, Tesla achieved its best sales month in 2024, driven by impressive sales figures. However, the company faces challenges as BYD Company...

Continue Reading
Bitcoin Bancorp's Strategic Leap with NASDAQ Ticker 'BCBC'

Updated Category News Views 114

Bitcoin Bancorp Announces NASDAQ Ticker Reservation Bitcoin Bancorp (Ticker: BULT), formerly known as Bullet Blockchain, Inc., has recently made waves in the financial sphere by securing the reservation of the NASDAQ ticker symbol 'BCBC'. This strategic move marks a significant step in the company’s ambitious plan to uplist to NASDAQ, further amplifying its presence in...

Continue Reading